|
Main | | | | |
| Brand Name | Zyprexa | | |
| Generic Name | olanzapine | | |
| Competition | paliperidone ER, bifeprunox, Seroquel | | |
| Indication | Schizophrenia, Bipolar Disorder. Best used in unstable schizophrenia, high-risk/mixed-bipolar patients, acute schizophrenia and bipolar | | |
| IP | Successfully litigated | | |
| | Work to maintain patient access at the state level--in 45 of 50 states without formulary restriction. FL, CA at risk. | | |
| | Double-digit growth in ex-US Zyprexa sales as penetration of atypicals increases. | | |
| | 40-60% of schizo patients only 20-40% of bipolar in EU | | |
| | | | |
| | | | |
| Rx | | TRx | NRx |
| | 12/18/2009 | 117723 | 53829 |
| | 12/11/2009 | 116406 | 52891 |
| | 12/4/2009 | 128647 | 56775 |
| | 11/27/2009 | 104242 | 44896 |
| | 11/20/2009 | 116685 | 53770 |
| | 11/13/2009 | 113476 | 51112 |
| | 11/6/2009 | 122441 | 54445 |
| | 10/30/2009 | 114922 | 51865 |
| | 6/1/2007 | 118958 | 50496 |
| | 5/25/2007 | 123390 | 53736 |
| | 6/1/2006 | 132085 | 54804 |